Avalo Therapeutics (AVTX) is set to join the small-cap Russell 2000 Index and the broad-market Russell 3000 Index. The addition is effective after the close of U.S. equity markets on June 26, 2026.

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.

WAYNE, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for ...

WAYNE, Pa., June 26, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing therapeutics targeting the IL-1β pathway for ...

Veritone, Inc. (NASDAQ: VERI), a leader in enterprise AI and data solutions, today announced that it is set to join the Russell 2000®and Russell 3000® Indexes at the conclusion of the June 2026 ...

FISHERS, IN / ACCESS Newswire / June 26, 2026 / American Resources Corporation (NASDAQ:AREC) ("American Resources" or the "Company"), a leader in the critical mineral supply chain, today announced ...

AtaiBeckley to be added to the Russell 2000® Index and the broad-market Russell 3000® Index as part of 2026 reconstitution The Russell U.S. Indexes have approximately $12.2 trillion in assets ...

Charles Schwab is partnering with Cboe Global Markets to offer new yes-or-no options contracts on the S&P 500, marking the brokerage’s first move into prediction markets. The planned product will ...

RideNow Group, Inc., the powersports dealership group that partners with most major powersports brands, is reporting that it expects to join the small-cap Russell 2000 Index and the broad-market ...